For the Inventor, By the Inventor

Enter assignee name

Boston, MA, United States of America

Servier Pharmaceuticals LLC

Calculating rank

USPTO Granted Patents = 24

Trademarks = 9

Forward Citations = 12

Loading Chart...

Loading Chart...

48 inventors (with patents filed for the assignee):

Jeremy Mark Travins (7 out of 52 patents)

Chong-Hui Gu (6 out of 21 patents)

Zenon D Konteatis (5 out of 15 patents)

4. Janeta Popovici-Muller (5 out of 45 patents)

5. Benjamin S Lane (3 out of 9 patents)

6. Zhihua Sui (3 out of 108 patents)

7. Ding Zhou (3 out of 22 patents)

8. Zhenwei Cai (3 out of 20 patents)

9. Shijie Zhang (3 out of 40 patents)

10. Jacob Paul Sizemore (3 out of 3 patents)

11. Robert Zahler (2 out of 74 patents)

12. Nelamangala Nagaraja (2 out of 4 patents)

13. Joshua Murtie (2 out of 4 patents)

14. Brandon Nicolay (2 out of 4 patents)

15. David Schenkein (2 out of 7 patents)

24 patents: Sort by Forward Citations

1. 12760021 - Carbonyl substituted diazaspiro compounds and its use (2026-10-13),

2. 12758551 - Substituted pyridazinones for use in the treatment of neuromuscular diseases (2026-10-13),

3. 12679820 - Cocrystals, pharmaceutical compositions thereof, and methods of treatment involving same (2026-07-14),

4. 12479824 - Method for preparing ivosidenib and an intermediate thereof (2025-11-25),

5. 12433895 - Therapeutically active compounds and their methods of use (2025-10-07),

6. 12303512 - Therapeutically active compounds and their methods of use (2025-05-20),

7. 12297179 - Crystalline and salt forms of an organic compound and pharmaceutical compositions thereof (2025-05-13),

8. 12290508 - Methods of use for trisubstituted benzotriazole derivatives (2025-05-06),

9. 12264148 - Ivosidenib forms and pharmaceutical compositions (2025-04-01),

10. 12064436 - Methods of treating brain tumors using combination therapy (2024-08-20),

11. 12042497 - Methods of treating brain tumors using combination therapy (2024-07-23),

12. RE49934 - Inhibitors of cellular metabolic processes (2024-04-23),

13. 11865079 - Therapeutically active compounds and their methods of use (2024-01-09),

14. 11851417 - Cocrystals, pharmaceutical compositions thereof, and methods of treatment involving same (2023-12-26),

15. 11844758 - Therapeutically active compounds and their methods of use (2023-12-19),

Company Overview

Servier Pharmaceuticals LLC is a global pharmaceutical company headquartered in Boston, MA, specializing in the development and manufacturing of innovative therapeutic solutions. The organization focuses on various therapeutic areas, including cardiology, oncology, diabetes, and neurology, aiming to address unmet medical needs through advanced research and development. With a commitment to improving patient outcomes, Servier leverages cutting-edge technology and scientific expertise to deliver high-quality medications and contribute to global health advancements.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

24 Patents

#99 in Boston, MA

#834 in Massachusetts

#13,900 in US

#26,701 in the World

Boston, MA, United States of America

Servier Pharmaceuticals LLC

Forward Citations = 12

48 inventors:

Jeremy Mark Travins (7 out of 52 patents)

Chong-Hui Gu (6 out of 21 patents)

Zenon D Konteatis (5 out of 15 patents)

4. Janeta Popovici-Muller (5 out of 45 patents)

5. Benjamin S Lane (3 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Servier Pharmaceuticals LLC. Retrieved from https://idiyas.com/company/servier-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…